Impax Laboratories (IPXL) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Net income before noncontrolling interest: -179.34M
Today's EPS Names:
PULM, UPLD, PNBK, More
Financial Fact:
Net income before noncontrolling interest: -179.34M
Today's EPS Names:
PULM, UPLD, PNBK, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q4 EPS of $0.16, $0.04 better than the analyst estimate of $0.12. Revenue for the quarter came in at $131.2 million versus the consensus estimate of $125.5 million.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight
- Sea Ltd. (SE) PT Raised to $153 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
